Nirmala Bhoo-Pathy: 15 years of breast cancer trends among women in a multiethnic, middle-income Asian setting
Nirmala Bhoo-Pathy shared on LinkedIn:
“We are thrilled to announce our latest publication in JCO Global Oncology, where we dive into 15 years of breast cancer trends among women in a multiethnic, middle-income Asian setting.
Key Findings: Significant improvements in survival rates especially for HER2-positive and advanced-stage cancers highlight the positive impact of enhanced cancer control efforts and treatment advancements. Despite this progress, late stage diagnoses and disparities in access to lifesaving therapies remain a challenge.
Policy Implications: Our study provides a thorough evaluation of current oncology care quality initiatives, validating the ongoing national cancer control efforts and advancements in treatment modalities. Policymakers can leverage these insights to enhance breast cancer downstaging efforts and drug policies, improving access to essential therapies for all.
Global Relevance: As one of the few studies offering detailed insights into the shifting breast cancer landscape in a resource-limited setting, our research serves as a model for other LMICs to track progress in their cancer control efforts.”
Trends in Presentation, Management, and Survival of Women With Breast Cancer in a Multiethnic, Middle-Income Asian Setting
Autors: Sharminii Jaya-Prakason, Yek-Ching Kong, Cheng-Har Yip, Mee-Hoong See, Nur Aishah Taib, Nur Fadhlina Abdul Satar, Suniza Jamaris, Li Ying Teoh, Rose Irnawaty Ibrahim, and Nirmala Bhoo-Pathy,
Source: Nirmala Bhoo-Pathy/LinkedIn
Nirmala Bhoo-Pathy is as a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician in Universiti Malaya Medical Centre, Malaysia.
She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014. Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy. Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN).